Expert consensus on clinical management of metabolic bone disease of prematurity (2021) / 中国当代儿科杂志
Chinese Journal of Contemporary Pediatrics
;
(12): 761-772, 2021.
Artigo
em Inglês
| WPRIM
| ID: wpr-888479
ABSTRACT
Metabolic bone disease of prematurity (MBDP) is a systemic bone disease with a reduction in bone mineral content due to disorder of calcium and phosphorus metabolism. There is still a lack of in-depth research and systematic understanding of MBDP in China, and there are many irregularities in clinical management of this disease. Based on relevant studies in China and overseas, Grading of Recommendations Assessment, Development and Evaluation was used to develop the expert consensus on the clinical management of MBDP, which provides recommendations from the following five aspects high-risk factors, screening/diagnosis, prevention, treatment, and post-discharge follow-up of MBDP, so as to provide relevant practitioners with recommendations on the clinical management of MBDP to reduce the incidence rate of MBDP and improve its short- and long-term prognosis.
Texto completo:
DisponíveL
Índice:
WPRIM (Pacífico Ocidental)
Assunto principal:
Alta do Paciente
/
Doenças Ósseas Metabólicas
/
Recém-Nascido Prematuro
/
Assistência ao Convalescente
/
Consenso
Tipo de estudo:
Guia de Prática Clínica
/
Estudo prognóstico
/
Fatores de risco
Limite:
Humanos
/
Recém-Nascido
Idioma:
Inglês
Revista:
Chinese Journal of Contemporary Pediatrics
Ano de publicação:
2021
Tipo de documento:
Artigo
Similares
MEDLINE
...
LILACS
LIS